İhsan Ateş
- Biochemistry top 5%
- Internal Medicine top 10%
-
- Thyroid Disorders and Treatments 9
- Clinical Biochemistry top 5%
- Nephrology top 10%
-
- COVID-19 Clinical Research Studies 21
-
- Pancreatitis Pathology and Treatment 13
-
- Inflammatory Biomarkers in Disease Prognosis 11
- Pancreatic and Hepatic Oncology Research 7
-
- Long-Term Effects of COVID-19 8
-
- Blood Pressure and Hypertension Studies 8
-
- Adipose Tissue and Metabolism 7
- Co-authors
- Nisbet YılmazÖzcan ErelCanan TopçuoğluFatma Meriç YılmazFatih DedeMustafa AltayErtuğrul Kayaçeti̇nMustafa Kaplan
- Journals
- Journal of Clinical Laboratory Analysis (3 papers)Vaccines (3 papers)Diabetes Research and Clinical Practice (3 papers)
- Partner nations
- TürkiyeCambodiaUnited States
In The Last Decade
İhsan Ateş
124 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 112
- Biochemistry 110
- Internal Medicine 53
- Endocrinology, Diabetes and Metabolism 226
- Clinical Biochemistry 77
- Nephrology 68
Countries citing papers authored by İhsan Ateş
This map shows the geographic impact of İhsan Ateş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İhsan Ateş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İhsan Ateş more than expected).
Fields of papers citing papers by İhsan Ateş
This network shows the impact of papers produced by İhsan Ateş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İhsan Ateş. The network helps show where İhsan Ateş may publish in the future.
Co-authorship network
The 25 scholars most cited alongside İhsan Ateş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 12 | |
| 13 | 2021 | 0 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2017 | 2 | |
| 19 | 2015 | 18 | |
| 20 | 2015 | 157 |
About İhsan Ateş
İhsan Ateş is a scholar working on Gastroenterology, Infectious Diseases, Internal Medicine, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 140 papers that have together received 1.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (21 papers), Pancreatitis Pathology and Treatment (13 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers), Thyroid Disorders and Treatments (9 papers), Long-Term Effects of COVID-19 (8 papers), Blood Pressure and Hypertension Studies (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Adipose Tissue and Metabolism (7 papers). The work is most often cited by research in Biochemistry (110 citations), Internal Medicine (53 citations), Endocrinology, Diabetes and Metabolism (226 citations), Clinical Biochemistry (77 citations) and Nephrology (68 citations). İhsan Ateş has collaborated with scholars based in Türkiye, Cambodia and United States. Frequent co-authors include Nisbet Yılmaz, Özcan Erel, Canan Topçuoğlu, Fatma Meriç Yılmaz, Fatih Dede, Mustafa Altay, Ertuğrul Kayaçeti̇n, Mustafa Kaplan, Nihal Özkayar and Serdar Güler. Their work appears in journals such as Journal of Clinical Laboratory Analysis, Vaccines, Diabetes Research and Clinical Practice, The American Journal of Emergency Medicine and European Journal of Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.